Newsoara Biopharma Co., Ltd.
Clinical trials sponsored by Newsoara Biopharma Co., Ltd., explained in plain language.
-
New drug HY6725 put to the test in healthy volunteers
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug, HY6725, in 74 healthy adults aged 18 to 55. The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo, and are followed for up to 150 days. This research does not ai…
Phase: PHASE1 • Sponsor: Newsoara Biopharma Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 02:29 UTC
-
New drug HY8931 put to the test in healthy volunteers
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug, HY8931, in 60 healthy adults aged 18 to 45. The main goal is to see if the drug is safe and how the body processes it. Participants will receive either the drug or a placebo and be followed for up to 90 days.
Phase: PHASE1 • Sponsor: Newsoara Biopharma Co., Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 02:17 UTC